Evaluation of pharmacokinetic properties of isobornylphenols in silico

Introduction. The potential of a new compound in the ongoing drugs discovery process is initially explored using virtual instruments, where its activity is predicted based on its molecular structure.

Aim. This study aimed to evaluate the pharmacokinetic parameters and possible toxicity of isobornyl compounds based on virtual tools.

Material and Methods. Several free Internet resources were used to assess the absorption, distribution, metabolism, excretion (ADME), and toxicity (T) of 2,6-diisobornyl-4-methylphenol (1, Dibornol), 2-hydroxy-3-isobornyl-5-methylbenzaldehyde (2), and 2-((di-n-butylamino) methyl)-6-isobornyl-4-methylphenol (3). Pharmacokinetic properties were calculated on ADMETlab platform. Toxicity and physical properties were evaluated using TEST software based on the structure-property quantification models of organic substances according to structure–property principle. Web server ProTox_II was used for acute toxicity assessment.

Results. Plasma protein binding degrees were 76,9% for (1), 85,9% for (2), and 91,8% for (3). All three compounds were capable of penetrating the blood-brain barrier. Dibornol was identified neither as a substrate nor as an inhibitor of P-glycoprotein unlike (2) and (3). The half-life of all compounds was short (about 2 hours); the clearance was slow (about 2 mL/min*kg). The study showed that (2) and (3) potentially exert the toxic effects during the developmental stage of the organism, while ADMETlab showed potential cardio- and hepatotoxicity for (2) and (3), respectively. All compounds had extremely low solubility in water, which affected the assessments of other indicators by TEST software. The ProTox_II server showed the extremely low toxicity LD50 for all compounds (toxicity class 5).

1. Shmyrev V.I., Kryzhanovsky S.M. Antioxidants in the complex therapy of the acute period of ischemic stroke. Effective Pharmacotherapy. 2010;(18):12–16 (In Russ.).

2. Chukanova E.I., Khodzhamzharov B.E., Chukanova A.S. Current possibilities of correction of oxidative stress in acute cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(11):79–82 (In Russ.).

3. Novikova N. Endothelial dysfunction – a new target of drug exposure in cardiovascular diseases. Vrach. 2005;8:51–53 (In Russ.).

4. Khabarova A.A., Bystrov M.V., Khasanova N.M., Orlova S.N. Clinical guidelines for the diagnosis and treatment of patients with acute cerebrovascular accidents in emergency situations. Moscow; 2015:16 (In Russ.).

5. Shchetinin P.P., Shchetinina A.P. Mechanisms of realization of antiradical activity of hindered phenols. Actual Problems of the Humanities and Natural Sciences. 2016;12(3):112–114 (In Russ.).

6. Mazaletskaya L.I., Sheludchenko I.N., Shishkina L.N., Kuchin A.V., Fedorova A.V., Chukicheva I.Yu. Kinetic characteristics of the reaction of isobornylphenols with peroxyradicals. Petrochemistry. 2011;51(5):354–359 (In Russ.).

7. Lutsky M.A., Zemskov A.M., Razuvaeva V.V., Lushnikova Yu.P., Karpova O.Yu. Oxidative stress is an indicator of metabolic disorders in the pathogenesis of cerebral stroke. S.S. Korsakov Journal of Neurology and Psychiatry. Special Issues. 2016;116(8):24–29 (In Russ.). DOI: 10.17116/jnevro20161168224-29.

8. Setkina S.B., Khishova O.M. Biopharmaceutical aspects of drug technology and ways of modifying bioavailability. Bulletin of Vitebsk State Medical University. 2014;13(4):162–172 (In Russ.).

9. Gurjar V.K., Pal D. Design, in silico studies, and synthesis of new 1.8-naphthyridine-3-carboxylic acid analogues and evaluation of their H1R antagonism effects. RSC Advances. 2020;10(23):13907–13921. DOI: 10.1039/D0RA00746C.

10. Raevsky O.A. Physicochemical descriptors in predicting ADMET characteristics of medicinal substances. Psychopharmacology and Biological Narcology. 2007;7(4):2-1913-2-1913 (In Russ.).

11. Mayr F., Vieider C., Temml V., Stuppner H., Schuster D. Open-access activity prediction tools for natural products. Case Study: hERG Blockers. Prog. Chem. Org. Nat. Prod. 2019;110:177–238. DOI: 10.1007/978-3-030-14632-0_6.

12. Buravlev E.V., Chukicheva I.Y., Kutchin A.V. Simple resolution of racemic salicylic aldehydes having an isobornyl substituent. Synthetic Communications. 2009;39(20):3639–3646. DOI: 10.1080/00397910902792648.

13. Shevchenko O.G., Plyusnina S.N., Buravlev E.V., Chukicheva I.Yu., Fedorova I.V., Shchukina O.V. et al. Structure – hemolytic activity relationships in isobornylphenols derivatives. Russian Chemical Bulletin. 2017;10:1881–1890 (In Russ.). DOI: 10.1007/s11172-017-1962-x.

14. Plotnikov M.B., Aliev O.I., Sidekhmenova A.V., Popova E.V., Ostrikova O.I., Kuchin A.V. et al. Synthesis and antiradical and hemorheological activity of compounds based on 2,6-diisobornyl- 4-methylphenol and polysaccharides. Pharmaceutical Chemistry Journal. 2018;51(10):863–866. DOI: 10.1007/s11094-018-1705-9.

15. Dong J., Wang N.-N., Yao Z.-J., Zhang L., Cheng Y., Ouyang D. et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J. Cheminform. 2018;10(1):29. DOI: 10.1186/s13321-018-0283-x.

16. Sushko I., Novotarskyi S., Körner R., Pandey A.K., Cherkasov A., Li J. еt al. Applicability domains for classification problems: Benchmarking of distance to models for AMES mutagenicity set. J. Chem. Inf. Model. 2010;50(12):2094–2111. DOI: 10.1021/ci100253r.

17. Chernysheva G.A., Smolkova V.I., Yanovskaya E.A., Kuchin A.V., Chukicheva I.Yu., Udut V.V. et al. Oral bioavailability of the phenolic antioxidant 4-methyl-2,6-diisobornylphenol. Bulletin of Experimental Biology and Medicine. 2016;161(4):505–507 (In Russ.). DOI: 10.1007/s10517-016-3448-5.

18. Globally Harmonized System of Classification and Labeling of Chemicals (GHS). Sixth revised edition. United Nations; 2017. URL: http://www.unece.org/ru/trans/danger/publi/ghs/ghs_rev07/07files_e0.html (available at 12.09.2020) (In Russ.).

19. Ivanov I.S. Neuroprotective and antithrombogenic activity of 4-methyl-2.6-diisobornylphenol: Abstr. ... Cand. Sci. (Biol.). Tomsk; 2009:23 (In Russ.).